Alabama Clears State-Level Path for Narrow Medical Cannabis Schedule III Change

Alabama health officials unanimously withdrew the state’s objection to the federal rule placing certain FDA-approved and qualifying state-licensed medical cannabis products in Schedule III. The move shows how states are adapting to the narrow federal medical framework, while Oklahoma operators still need to distinguish it from broader marijuana rescheduling.